Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06966362 · ClinicalTrials.gov registry record · Phase 4
Varenicline for Smoking Reduction in Veterans Not Ready To Quit
A Phase 4 study, sponsored by VA Office of Research and Development.
- Not yet
- Registry status
- Phase 4
- Development phase
- 400
- Enrollment target
NCT06966362: Clinical Trial Phase 4 study, sponsored by VA Office of Research and Development.
NCT06966362 is a Phase 4 study that has not yet begun recruiting, run by VA Office of Research and Development. The registered enrollment target is 400 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06966362, a Phase 4 study, has not yet begun recruiting, sponsored by VA Office of Research and Development.
- NOT YET RECRUITING
- Registry status
- Phase 4
- Development phase
- 400 participants
- Enrollment target
Study Summary
In order to reduce the prevalence of cigarette smoking among Veterans, it is vital that healthcare providers offer effective tobacco treatment to all Veterans who smoke, including those not ready to make a quit attempt. Smoking treatments currently available to Veterans who are not ready to quit are only weakly effective. This project will generate new knowledge about the effectiveness of a promising varenicline-based intervention designed to increase quit attempts and long-term abstinence in Veterans who are initially not ready to quit. This project has great potential to engage Veterans not ready to quit smoking in treatment that increases quit attempts and quitting success, thereby reducing morbidity and mortality caused by smoking in Veterans.
Interventions
- DRUG Motivation-Phase Varenicline
- DRUG Motivation-Phase Nicotine Mini-Lozenge
- DRUG Cessation-Phase Combination Nicotine Replacement Therapy (NRT)
- DRUG Cessation-Phase Varenicline
- BEHAVIORAL Motivation-Phase Counseling
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 400 participants |
| Start Date | 2026-07-20 |
| Est. Completion | 2030-06-28 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06966362
The ClinicalTrials.gov registry entry for NCT06966362 describes a study currently listed as not yet recruiting, categorized as Phase 4. The registered enrollment target is 400 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is VA Office of Research and Development, which has 1,668 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Motivation-Phase Varenicline is the first listed.
NCT06966362 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06966362 about?
NCT06966362 is a clinical study titled "Varenicline for Smoking Reduction in Veterans Not Ready To Quit". In order to reduce the prevalence of cigarette smoking among Veterans, it is vital that healthcare providers offer effective tobacco treatment to all Veterans who smoke, including those not ready to make a quit attempt. Smoking treatments currently available to Veterans who are not ready to quit are...
What is the current status of trial NCT06966362?
This trial is currently not yet recruiting. It is a Phase 4 study. The enrollment target is 400 participants. The study started on 2026-07-20. Estimated completion is 2030-06-28.
What interventions are being tested in trial NCT06966362?
The interventions under investigation include: Motivation-Phase Varenicline (DRUG), Motivation-Phase Nicotine Mini-Lozenge (DRUG), Cessation-Phase Combination Nicotine Replacement Therapy (NRT) (DRUG), Cessation-Phase Varenicline (DRUG), Motivation-Phase Counseling (BEHAVIORAL).
Who is sponsoring clinical trial NCT06966362?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.